Menu


Cystic Fibrosis Research Award Given to California Institute for Medical Research

San Jose, CA - February 19, 2014 - The California Institute for Medical Research (CIMR) today announced that a group of its researchers have won an award for studies on the role of microbes in the progression of lung disease in the genetic disorder, cystic fibrosis (CF). Cystic fibrosis is a lethal disease (1 in 4000 births, over 70,000 persons worldwide) that is marked by disease in many organ systems, especially the lung.

The CIMR researchers are studying the disease roles of Aspergillus, a common fungus, and Pseudomonas, a common bacterium; these two microbes commonly persistently infect CF patient airways.

The award is from the Child Health Research Initiative, and the award is to a consortium that includes the CIMR group, scientists in the Arts & Sciences, Medical, & Engineering Schools at Stanford, and others at the University of California, Berkeley and Children's Hospital, Oakland. The largest part of the activities funded will be at CIMR, and involves CIMR researchers David A. Stevens, Karl V. Clemons, and Jose A.G. Ferreira. These CIMR researchers had received funding from the Flatley Foundation and a Brazilian governmental agency for their earlier and ongoing work on CF. Drs. Stevens and Clemons are already internationally-acclaimed researchers in fungal diseases, and Dr. Ferreira joined CIMR from Brazil for 2 years to work with them. Their CF project also includes a student, Jack Penner. Their current work is being presented this month at an international meeting in Madrid, Spain. The amount of the award is $200,000, for 2 years.

CIMR, on the grounds of Santa Clara Valley Medical Center in San Jose and governed by a Board of community leaders, was founded by Santa Clara County physicians 50 years ago, and enjoys financial support from philanthropic individuals in the South Bay, as well as from foundations and governmental agencies.  Visit www.cimr.org.